About 6-8 months ago, an inside source told me personally, that they were very happy with Japan-Tobacco, because it did not get into their business. However, Roche was another story. At times it seemed like Roche wanted to run the company. And that, they surely did not like.
I am not at all surprised about seing Roche go. And as a businessman, if I can afford to run my business, and take new drugs to market, why am I going to let someone tell me what to do, and take a bite off my profits?
With regards to the inside trading, if you look back, at least to October 1st, you will find several instances where big transactions in the options markets were taking place ahead of news. And David Crossen has been downgrading the stock on wrong,misguided information. And giving out at least misleading info. He should know very well that Glaxo and Vertex have the same drug.
JLL |
